Viewing Study NCT06226766


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-27 @ 4:13 AM
Study NCT ID: NCT06226766
Status: TERMINATED
Last Update Posted: 2025-09-10
First Post: 2023-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-01-18
Start Date Type: ACTUAL
Primary Completion Date: 2025-07-31
Primary Completion Date Type: ACTUAL
Completion Date: 2025-07-31
Completion Date Type: ACTUAL
First Submit Date: 2023-12-22
First Submit QC Date: None
Study First Post Date: 2024-01-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-04
Last Update Post Date: 2025-09-10
Last Update Post Date Type: ESTIMATED